Similar articles for PMID: 18001228

Year	Number of Results
1984	1
1996	1
1998	1
1999	5
2000	9
2001	19
2002	35
2003	31
2004	28
2005	23
2006	29
2007	29
2008	17
2009	18
2010	15
2011	17
2012	17
2013	13
2014	15
2015	7
2016	2
2017	1
2018	1
2019	2
2024	0

1

Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.

Cruess DG, Minor S, Antoni MH, Millon T. Cruess DG, et al. J Pers Assess. 2007 Dec;89(3):277-90. doi: 10.1080/00223890701629805. J Pers Assess. 2007. PMID: 18001228

2

Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.

Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, Tyndall M, Wood E. Kerr T, et al. Antivir Ther. 2004 Jun;9(3):407-14. Antivir Ther. 2004. PMID: 15259903

3

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K. Van Vaerenbergh K. Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.

4

Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA.

Murphy DA, Wilson CM, Durako SJ, Muenz LR, Belzer M; Adolescent Medicine HIV/AIDS Research Network. Murphy DA, et al. AIDS Care. 2001 Feb;13(1):27-40. doi: 10.1080/09540120020018161. AIDS Care. 2001. PMID: 11177463

5

Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.

Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS. Palepu A, et al. Antivir Ther. 2004 Oct;9(5):713-9. Antivir Ther. 2004. PMID: 15535408

6

Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice.

Stone VE. Stone VE. Clin Infect Dis. 2001 Sep 15;33(6):865-72. doi: 10.1086/322698. Epub 2001 Aug 13. Clin Infect Dis. 2001. PMID: 11512092 Review.

7

Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV.

Zorrilla CD, Santiago LE, Knubson D, Liberatore K, Estronza G, Colón O, Acevedo M. Zorrilla CD, et al. Cell Mol Biol (Noisy-le-grand). 2003 Dec;49(8):1187-92. Cell Mol Biol (Noisy-le-grand). 2003. PMID: 14983985

8

Using the Millon Behavioral Medicine Diagnostic (MBMD) to evaluate the need for mental health services in association with biomarkers of disease status among HIV positive men and women.

Burbridge C, Cruess DG, Antoni MH, Meagher S. Burbridge C, et al. J Clin Psychol Med Settings. 2011 Mar;18(1):30-8. doi: 10.1007/s10880-011-9231-x. J Clin Psychol Med Settings. 2011. PMID: 21340710

9

HIV-related knowledge and adherence to HAART.

Weiss L, French T, Finkelstein R, Waters M, Mukherjee R, Agins B. Weiss L, et al. AIDS Care. 2003 Oct;15(5):673-9. doi: 10.1080/09540120310001595159. AIDS Care. 2003. PMID: 12959818

10

Medication adherence for HIV positive women caring for children: in their own words.

Wood SA, Tobias C, McCree J. Wood SA, et al. AIDS Care. 2004 Oct;16(7):909-13. doi: 10.1080/09540120412331290158. AIDS Care. 2004. PMID: 15385246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

321 results

Results by year